Published in Cell Mol Neurobiol on November 25, 2010
Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev (2011) 2.14
Preferential use of unobstructed lateral portals as the access route to the pore of human ATP-gated ion channels (P2X receptors). Proc Natl Acad Sci U S A (2011) 1.20
Fusion-activated Ca2+ entry via vesicular P2X4 receptors promotes fusion pore opening and exocytotic content release in pneumocytes. Proc Natl Acad Sci U S A (2011) 1.07
Multiple roles of the extracellular vestibule amino acid residues in the function of the rat P2X4 receptor. PLoS One (2013) 0.83
Allosteric regulation of the P2X4 receptor channel pore dilation. Pflugers Arch (2014) 0.83
Regulation of ATP-gated P2X channels: from redox signaling to interactions with other proteins. Antioxid Redox Signal (2013) 0.83
ATP binding site mutagenesis reveals different subunit stoichiometry of functional P2X2/3 and P2X2/6 receptors. J Biol Chem (2012) 0.82
Reconstruction of Cell Surface Densities of Ion Pumps, Exchangers, and Channels from mRNA Expression, Conductance Kinetics, Whole-Cell Calcium, and Current-Clamp Voltage Recordings, with an Application to Human Uterine Smooth Muscle Cells. PLoS Comput Biol (2016) 0.75
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis (1997) 57.27
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem (2009) 23.19
Molecular physiology of P2X receptors. Physiol Rev (2002) 13.61
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature (2003) 6.04
P2X receptors as cell-surface ATP sensors in health and disease. Nature (2006) 4.55
Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature (2009) 4.18
Signaling at purinergic P2X receptors. Annu Rev Physiol (2009) 3.41
Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nat Neurosci (1999) 2.63
Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med (2005) 2.59
An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J (1996) 2.48
Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology (1997) 2.24
Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci (1999) 2.10
Identification of amino acid residues contributing to the ATP-binding site of a purinergic P2X receptor. J Biol Chem (2000) 2.08
Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J (1997) 2.02
Contribution of calcium ions to P2X channel responses. J Neurosci (2004) 2.01
ATP-gated P2X cation-channels. Neuropharmacology (2008) 2.00
A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett (1995) 1.99
P2X4: an ATP-activated ionotropic receptor cloned from rat brain. Proc Natl Acad Sci U S A (1996) 1.98
Distinct Localization of P2X receptors at excitatory postsynaptic specializations. J Neurosci (2001) 1.97
Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci (2008) 1.97
Identification of an intersubunit cross-link between substituted cysteine residues located in the putative ATP binding site of the P2X1 receptor. J Neurosci (2007) 1.79
Gating the pore of P2X receptor channels. Nat Neurosci (2008) 1.70
New structure enlivens interest in P2X receptors. Trends Pharmacol Sci (2010) 1.66
Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J Cell Sci (2007) 1.62
Ivermectin Interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron (2007) 1.62
A domain contributing to the ion channel of ATP-gated P2X2 receptors identified by the substituted cysteine accessibility method. J Neurosci (1998) 1.61
Conserved cysteine residues in the extracellular loop of the human P2X(1) receptor form disulfide bonds and are involved in receptor trafficking to the cell surface. Mol Pharmacol (2002) 1.61
P2X receptor trafficking in neurons is subunit specific. J Neurosci (2002) 1.60
Amino acid residues involved in gating identified in the first membrane-spanning domain of the rat P2X(2) receptor. J Biol Chem (2001) 1.55
Mutational analysis of the conserved cysteines of the rat P2X2 purinoceptor. J Neurosci (2002) 1.54
Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors. J Neurophysiol (1997) 1.54
Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J Neurosci (1998) 1.52
Altered hippocampal synaptic potentiation in P2X4 knock-out mice. J Neurosci (2006) 1.44
Polar residues of the second transmembrane domain influence cation permeability of the ATP-gated P2X(2) receptor. J Biol Chem (2001) 1.34
Secondary structure and gating rearrangements of transmembrane segments in rat P2X4 receptor channels. J Gen Physiol (2005) 1.30
Gated access to the pore of a P2X receptor: structural implications for closed-open transitions. J Biol Chem (2010) 1.29
Analysis of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent immune cells. J Biol Chem (2009) 1.26
P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages. Br J Pharmacol (2003) 1.25
Homotrimeric complexes are the dominant assembly state of native P2X7 subunits. Biochem Biophys Res Commun (2008) 1.25
Role of ectodomain lysines in the subunits of the heteromeric P2X2/3 receptor. Mol Pharmacol (2006) 1.24
Identification of a non-canonical tyrosine-based endocytic motif in an ionotropic receptor. J Biol Chem (2002) 1.24
Molecular determinants of the agonist binding domain of a P2X receptor channel. Mol Pharmacol (2005) 1.23
Participation of the Lys313-Ile333 sequence of the purinergic P2X4 receptor in agonist binding and transduction of signals to the channel gate. J Biol Chem (2006) 1.23
Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. J Neurochem (2005) 1.22
A C-terminal lysine that controls human P2X4 receptor desensitization. J Biol Chem (2006) 1.21
Polar residues in the second transmembrane domain of the rat P2X2 receptor that affect spontaneous gating, unitary conductance, and rectification. J Neurosci (2009) 1.21
Orthosteric and allosteric binding sites of P2X receptors. Eur Biophys J (2008) 1.20
Acidic amino acids impart enhanced Ca2+ permeability and flux in two members of the ATP-gated P2X receptor family. J Gen Physiol (2007) 1.16
Contribution of transmembrane regions to ATP-gated P2X2 channel permeability dynamics. J Biol Chem (2004) 1.16
Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem Biophys Res Commun (2006) 1.12
Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels. Am J Physiol Cell Physiol (2003) 1.10
Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin. Pflugers Arch (2008) 1.08
P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. J Gen Physiol (2010) 1.07
On the contribution of the first transmembrane domain to whole-cell current through an ATP-gated ionotropic P2X receptor. J Neurosci (2001) 1.06
Inhibition by ethanol of rat P2X(4) receptors expressed in Xenopus oocytes. Br J Pharmacol (2000) 1.05
Dissecting the facilitator and inhibitor allosteric metal sites of the P2X4 receptor channel: critical roles of CYS132 for zinc potentiation and ASP138 for copper inhibition. J Biol Chem (2007) 1.04
Mutation of histidine 286 of the human P2X4 purinoceptor removes extracellular pH sensitivity. J Physiol (2000) 1.02
Gain and loss of channel function by alanine substitutions in the transmembrane segments of the rat ATP-gated P2X2 receptor. J Neurosci (2004) 1.02
The first transmembrane domain of the P2X receptor subunit participates in the agonist-induced gating of the channel. J Biol Chem (2001) 1.00
Dynamic regulation of the P2X4 receptor in alveolar macrophages by phagocytosis and classical activation. Eur J Immunol (2009) 1.00
Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol (2009) 0.99
An uncharged region within the N terminus of the P2X6 receptor inhibits its assembly and exit from the endoplasmic reticulum. Mol Pharmacol (2006) 0.98
On the role of the first transmembrane domain in cation permeability and flux of the ATP-gated P2X2 receptor. J Biol Chem (2007) 0.97
Histidine 140 plays a key role in the inhibitory modulation of the P2X4 nucleotide receptor by copper but not zinc. J Biol Chem (2003) 0.96
Zinc and copper modulate differentially the P2X4 receptor. J Neurochem (2000) 0.95
A point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors. J Neurochem (2009) 0.95
Purinergic P2X(2) receptor desensitization depends on coupling between ectodomain and C-terminal domain. Mol Pharmacol (2002) 0.91
Extracellular histidine residues identify common structural determinants in the copper/zinc P2X2 receptor modulation. J Neurochem (2005) 0.89
Functional relevance of aromatic residues in the first transmembrane domain of P2X receptors. J Neurochem (2009) 0.89
The role of positively charged amino acids in ATP recognition by human P2X1 receptors J Biol Chem (2000) 0.88
Characterization of purinergic P2X4 receptor channels expressed in anterior pituitary cells. Am J Physiol Endocrinol Metab (2009) 0.88
Roles of conserved ectodomain cysteines of the rat P2X4 purinoreceptor in agonist binding and channel gating. Physiol Res (2010) 0.86
Atypical P2X receptor pharmacology in two human osteoblast-like cell lines. Br J Pharmacol (2009) 0.84
Heavy metals modulate the activity of the purinergic P2X4 receptor. Toxicol Appl Pharmacol (2005) 0.84
Expression of P2X purinoceptors in PC12 phaeochromocytoma cells. Clin Exp Pharmacol Physiol (2007) 0.81
Dependence of purinergic P2X receptor activity on ectodomain structure. J Biol Chem (2003) 0.79
Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev (2011) 2.14
Biophysical basis of pituitary cell type-specific Ca2+ signaling-secretion coupling. Trends Endocrinol Metab (2005) 1.26
Molecular determinants of the agonist binding domain of a P2X receptor channel. Mol Pharmacol (2005) 1.23
Participation of the Lys313-Ile333 sequence of the purinergic P2X4 receptor in agonist binding and transduction of signals to the channel gate. J Biol Chem (2006) 1.23
14-3-3 Protein interacts with nuclear localization sequence of forkhead transcription factor FoxO4. Biochemistry (2005) 1.18
Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem Biophys Res Commun (2006) 1.12
Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels. Am J Physiol Cell Physiol (2003) 1.10
Role of aromatic and charged ectodomain residues in the P2X(4) receptor functions. J Neurochem (2007) 1.10
Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin. Pflugers Arch (2008) 1.08
The 14-3-3 protein affects the conformation of the regulatory domain of human tyrosine hydroxylase. Biochemistry (2008) 1.07
Expression and roles of pannexins in ATP release in the pituitary gland. Endocrinology (2011) 1.04
Ionic interactions are essential for TRPV1 C-terminus binding to calmodulin. Biochem Biophys Res Commun (2008) 0.98
14-3-3 protein masks the DNA binding interface of forkhead transcription factor FOXO4. J Biol Chem (2009) 0.95
14-3-3 protein C-terminal stretch occupies ligand binding groove and is displaced by phosphopeptide binding. J Biol Chem (2004) 0.95
Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs. Mol Endocrinol (2006) 0.94
14-3-3zeta C-terminal stretch changes its conformation upon ligand binding and phosphorylation at Thr232. J Biol Chem (2003) 0.93
Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner. Cancer Res (2011) 0.92
Dependence of multidrug resistance protein-mediated cyclic nucleotide efflux on the background sodium conductance. Mol Pharmacol (2009) 0.91
Molecular, pharmacological and functional properties of GABA(A) receptors in anterior pituitary cells. J Physiol (2008) 0.90
Functional relevance of aromatic residues in the first transmembrane domain of P2X receptors. J Neurochem (2009) 0.89
Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding. J Biol Chem (2007) 0.89
Gating properties of the P2X2a and P2X2b receptor channels: experiments and mathematical modeling. J Gen Physiol (2012) 0.88
Molecular dissection of purinergic P2X receptor channels. Ann N Y Acad Sci (2005) 0.87
The interactions of the C-terminal region of the TRPC6 channel with calmodulin. Neurochem Int (2009) 0.86
Dual gating mechanism and function of P2X7 receptor channels. Biophys J (2013) 0.86
The C-terminal segment of yeast BMH proteins exhibits different structure compared to other 14-3-3 protein isoforms. Biochemistry (2010) 0.85
Structural basis for the 14-3-3 protein-dependent inhibition of the regulator of G protein signaling 3 (RGS3) function. J Biol Chem (2011) 0.85
Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7. Biochem Biophys Res Commun (2005) 0.84
Signaling by purinergic receptors and channels in the pituitary gland. Mol Cell Endocrinol (2009) 0.84
14-3-3 protein interacts with and affects the structure of RGS domain of regulator of G protein signaling 3 (RGS3). J Struct Biol (2010) 0.84
Role of individual phosphorylation sites for the 14-3-3-protein-dependent activation of yeast neutral trehalase Nth1. Biochem J (2012) 0.84
Structure of the human FOXO4-DBD-DNA complex at 1.9 Å resolution reveals new details of FOXO binding to the DNA. Acta Crystallogr D Biol Crystallogr (2010) 0.83
Multiple roles of the extracellular vestibule amino acid residues in the function of the rat P2X4 receptor. PLoS One (2013) 0.83
Conserved ectodomain cysteines are essential for rat P2X7 receptor trafficking. Purinergic Signal (2012) 0.81
TRPV1 channels are functionally coupled with BK(mSlo1) channels in rat dorsal root ganglion (DRG) neurons. PLoS One (2013) 0.81
Structural basis of the 14-3-3 protein-dependent activation of yeast neutral trehalase Nth1. Biochim Biophys Acta (2013) 0.81
Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding. J Neurochem (2004) 0.80
Highly conserved tyrosine 37 stabilizes desensitized states and restricts calcium permeability of ATP-gated P2X3 receptor. J Neurochem (2011) 0.80
ATP binding site on the C-terminus of the vanilloid receptor. Arch Biochem Biophys (2007) 0.80
Dependence of purinergic P2X receptor activity on ectodomain structure. J Biol Chem (2003) 0.79
Structural modulation of phosducin by phosphorylation and 14-3-3 protein binding. Biophys J (2012) 0.79
Potentiation of inhibitory synaptic transmission by extracellular ATP in rat suprachiasmatic nuclei. J Neurosci (2013) 0.79
The role of proline residues in the structure and function of human MT2 melatonin receptor. J Pineal Res (2008) 0.79
Detailed kinetic analysis of the interaction between the FOXO4-DNA-binding domain and DNA. Biophys Chem (2013) 0.78
14-3-3 proteins--a family of universal scaffolds and regulators. Semin Cell Dev Biol (2011) 0.77
Circadian rhythmicity in AVP secretion and GABAergic synaptic transmission in the rat suprachiasmatic nucleus. Ann N Y Acad Sci (2005) 0.77
Day-night variations in zinc sensitivity of GABAA receptor-channels in rat suprachiasmatic nucleus. Brain Res Mol Brain Res (2003) 0.77
P2X receptor channels in endocrine glands. Wiley Interdiscip Rev Membr Transp Signal (2013) 0.75
The bidirectional phase-shifting effects of melatonin on the arginine vasopressin secretion rhythm in rat suprachiasmatic nuclei in vitro. Brain Res Mol Brain Res (2003) 0.75